中文名称:
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐
中文同义词:
(1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPANAMINIUM (2R)-HYDROXY(PHENYL)ETHANOATE别名 (ALPHAR)-ALPHA-HYDROXYBENZENEACETIC ACID COMPD. WITH (1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPA;(1R,2S)-2-(3,4-二氟苯基)环丙胺/(R)-扁桃酸盐 1G;(1S,2R)-2-(3,4-二氟苯基)环丙胺扁桃酸盐(替卡格雷中间体) 50MG;52(1R,2S)-2-(3,4-二氟苯基)环丙胺;替卡格雷中间体4;(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐;反式(1R,2S)-2- (2,3-二氟苯基)环丙胺扁桃酸盐;(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐(1:1)
英文名称:
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
英文同义词:
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanamine(S)-(carboxylato(phenyl)methyl)holmium;(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaMine (2R)-Hydroxy(phenyl)ethanoate;(αR)-α-Hydroxybenzeneacetic Acid coMpd. with (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaMine;trans-(1R,2S)-2-(2,3-difluorophenyl)cyclopropylaMine Mandelat;(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate;(alphaR)-alpha-Hydroxybenzeneacetic acid compd. with (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine;(αR)-(1R,2S)-α-hydroxy-Benzeneacetic acid-coMpd.with 2-(3,4-difluorophenyl)cyclopropanaMine(1:1);Ticagrelor InterMediate 4
相关类别:
替卡格雷中间体;中间体;杂质对照品;医药中间体;替卡格雷原料三;原料药;Intermediate of Ticagrelor;精细化工;有机化学;手性中间体;其他;原料药;有机中间体
概述
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐为淡黄色至白色粉末,可做医药中间体。
用途
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐是制备口服活性可逆P2Y12受体拮抗剂(例如Ticagrelor(T437700))以预防血栓形成的中间体。
应用
(1R,2S)-2-(3,4-二氟苯基)环丙胺(R)-扁桃酸盐为羧酸类衍生物,可用作抗凝血原料药替卡格雷的中间体。
制备
通过樟脑锍叶立德I与丙烯腈的环丙烷化反应,立体选择性合成(1R,2R)-2-(3,4-二氟代苯基)环丙基腈II,再经水解和holfman降解反应得到目标产物, (1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐。